GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 51 filers reported holding GEMINI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,014,000 | +169.0% | 2,447,477 | +177.3% | 0.01% | +233.3% |
| Q2 2022 | $1,492,000 | +21.6% | 882,612 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $1,227,000 | -38.2% | 882,612 | +29.3% | 0.00% | -50.0% |
| Q4 2021 | $1,986,000 | -35.1% | 682,612 | -9.9% | 0.00% | -33.3% |
| Q3 2021 | $3,061,000 | -46.4% | 757,612 | -14.2% | 0.01% | -45.5% |
| Q2 2021 | $5,710,000 | -53.2% | 882,612 | -1.9% | 0.01% | -56.0% |
| Q1 2021 | $12,195,000 | – | 900,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $15,755,000 | 6.20% |
| Orbimed Advisors | 5,826,224 | $37,696,000 | 0.38% |
| Boxer Capital, LLC | 1,300,000 | $8,411,000 | 0.30% |
| Ikarian Capital, LLC | 426,455 | $2,759,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,135,000 | $13,813,000 | 0.21% |
| JS Capital Management LLC | 474,457 | $3,070,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,618,000 | 0.09% |
| Alyeska Investment Group, L.P. | 837,584 | $5,419,000 | 0.06% |
| Virtus ETF Advisers LLC | 19,673 | $127,000 | 0.05% |
| Caption Management, LLC | 384,900 | $2,488,000 | 0.03% |